Schedule of Outstanding Warrants (Details) - $ / shares |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Warrants | |||
| Warrants outstanding, Balance | 550,039 | 214,400 | 214,400 |
| Weighted Average Exercise Price outstanding, Balance | $ 2.47 | $ 5.92 | $ 5.92 |
| Warrants, Issued | 335,639 | ||
| Weighted Average Exercise Price, Issued | $ 11.44 | ||
| Warrants, Exercised | |||
| Weighted Average Exercise Price, Exercised | |||
| Warrants, Terminated/Expired | |||
| Weighted Average Exercise Price, Terminated/Expired | |||
| Warrants outstanding, Balance | 550,039 | 550,039 | 214,400 |
| Weighted Average Exercise Price outstanding, Balance | $ 2.47 | $ 2.47 | $ 5.92 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants forfeiture/expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants issued. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|